A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
Recruiting · NCT06722170 · Registry updated 2025-07-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss | Ear Diseases, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease | Recruiting | Not applicable | 2025-07-25 | NCT06722170 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yilai Shu | 2 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eye & ENT Hospital of Fudan University | Shanghai | China | 17 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 103 |